MSB

4.69%

$1.45 mesoblast limited

MSB Monday Opening Price, page-122

First 122 Last

Share
Profile

Follow
DocMcstuffins

7,872 Posts.

1354

26/04/20

23:01

Post #: 44267791
Share

Originally posted by dolcevita: ↑

Listen mate. I am legally qualified. And I don't come into threads and berate people for not knowing the law of evidence, because in TV shows that gets thrown out the window and often people get the wrong end of the stick. And often people misunderstand the law.

But I ask myself if it will be useful to the discussion, or not?

The point is, substantively what's going on here? You can select various statements out of context all you like.

Nobody is representing themselves as medical researchers per se, although we have had some, none today and none with your myopic views. You're simply out of your depth in understanding how revolutionary this actually is.

We understand how this works at a practical level. We have been to AGMs and asked questions. For years. We each add different perspectives. I have a legal regulatory background and years ago foreshadowed that the FDA protocols for stem cells would be revised because DRUG clinical trials are onerous and inappropriate. I was correct. This would not be forseen by the likes of you because you're welded to procedures. Not realising what you are looking at here. There are people with various strengths in here. To you we're just a bunch of yobbos with a dream.

So what is going on here? Some of us are speculating that this particular application will be fast tracked and one of the signals is that the patient recruitment has already been satisfied. That's expeditious. And there are push pull mechanisms in operation here. The mortality rate and the fact that we have a pandemic tends to indicate a bit of a push mechanism could be in operation.

The FDA itself has written papers on how they understand they need to modernise and facilitate approvals, while applying sound science. I suggest you find them. And have a bit of a rethink. Ask yourself why MSB would bother with this rigour. Because it is rigorous science.

You come in here and haven't added anything useful. You have managed to get up people's nose. And revel in it.

Finally you admit you're a bit jealous. I think that's finally a chink of truth and self awareness entering the picture.

Step back and have a bit of respect for what you don't understand. Also some of us are saying that anything under $10 is a bargain. I sincerely think that, so I don't know what you're on about.

Expand

I've obviously managed to inadvertently get under your skin by coming around and suggesting that these results may not be what they seem on the surface.

While also explaining how I actually think the fundamentals of MSB are interesting from a medical standpoint.

But you've completely glossed over what I've actually come here and said.

You aren't interested in hearing what you don't want to, and that's fine my friend.

But if a bunch of doctors had huge reservations over the interpretation of a preliminary data set involving a medical company targeted at patients they are actively involved in treating, I'd want to know if I was an investor. (It's not just me who was discussing this around the ICU today).

To each their own.

Good luck to all

Last edited by DocMcstuffins: 26/04/20

MSB Price at posting: $2.73 Sentiment: None Disclosure: Not Held
5 Upvote

0 Great analysis

Reply

Top Stories

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

IMA

Issues emerging as Australian companies tackle critical minerals challenge

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

There are more pages in this discussion • 191 more messages in this thread...

First 122 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.45		Change 0.065(4.69%)		Mkt cap ! $1.655B

Open	High	Low	Value	Volume
$1.39	$1.50	$1.38	$7.016M	4.856M

Buyers (Bids)

No.	Vol.	Price($)
1	10425	$1.44

Sellers (Offers)

Price($)	Vol.	No.
$1.45	44243	5

View Market Depth

No.	Vol.	Price($)
1	10425	1.440
2	9000	1.435
4	62190	1.430
1	473	1.425
1	5000	1.420

Price($)	Vol.	No.
1.450	16999	2
1.455	17000	1
1.465	24896	3
1.470	112738	6
1.475	1800	1

Last trade - 16.10pm 11/10/2024 (20 minute delay)

MSB (ASX) Chart

MSB Monday Opening Price, page-122

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Issues emerging as Australian companies tackle critical minerals challenge

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Cauldron Energy reports "excellent" uranium assays in latest drill run

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

MSB Monday Opening Price, page-122

Top Stories

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Issues emerging as Australian companies tackle critical minerals challenge

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Cauldron Energy reports "excellent" uranium assays in latest drill run

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News